Myomo (MYO) Net Cash Flow (2016 - 2025)
Myomo (MYO) posted Net Cash Flow of -$1.7 million for Q3 2025, up 69.96% on a QoQ basis from -$5.6 million in Q2 2025, and down 249.28% year-over-year from $1.1 million in Q3 2024.
Myomo (MYO) Net Cash Flow (2016 - 2025) Analysis & Trends
Myomo's Net Cash Flow history runs 10 years deep, the most recent figure standing at -$1.7 million for Q3 2025.
- Quarterly Net Cash Flow fell 249.28% year-over-year to -$1.7 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$11.9 million (down 166.59% YoY) and the FY2024 annual result came in at $17.9 million, up 1084.71% from the prior year.
- Net Cash Flow was -$1.7 million for Q3 2025 at Myomo, up from -$5.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $17.8 million in Q4 2024 and bottomed at -$5.6 million in Q2 2025.
- A 5-year average of $32550.4 and a median of -$1.4 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow soared 29127.52% — and 2025, when it slumped 1455.79%.
- Myomo's Net Cash Flow stood at $2.9 million in 2021, then slumped by 171.9% to -$2.1 million in 2022, then jumped by 97.07% to -$61261.0 in 2023, then surged by 29127.52% to $17.8 million in 2024, then tumbled by 109.5% to -$1.7 million in 2025.
- Business Quant data shows MYO's Net Cash Flow at -$1.7 million in Q3 2025, -$5.6 million in Q2 2025, and -$4.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.69 Mn |
| Sep 30, 2025 | -1.69 Mn |
| Jun 30, 2025 | -5.62 Mn |
| Jun 30, 2025 | -5.62 Mn |
| Mar 31, 2025 | -4.61 Mn |
| Mar 31, 2025 | -4.61 Mn |
| Dec 31, 2024 | 17.78 Mn |
| Dec 31, 2024 | 17.78 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 414,711.00 |
| Jun 30, 2024 | 414,711.00 |
| Mar 31, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Dec 31, 2023 | -61,261.00 |
| Dec 31, 2023 | -61,261.00 |
| Sep 30, 2023 | 919,384.00 |
| Sep 30, 2023 | 919,384.00 |
| Jun 30, 2023 | -3.26 Mn |
| Jun 30, 2023 | -3.26 Mn |